Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigms

Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigms

Bibliographic Details
Main Authors: Jiang Chen, Dan G. Duda
Format: Article
Language:English
Published: Elsevier 2020-02-01
Series:EBioMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396420300190
id doaj-9f71faa6822b4e4cb31eb8edad534d7b
record_format Article
spelling doaj-9f71faa6822b4e4cb31eb8edad534d7b2020-11-24T22:00:23ZengElsevierEBioMedicine2352-39642020-02-0152Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigmsJiang Chen0Dan G. Duda1Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, 100 Blossom St, Cox-734, Boston, MA 02114, USA; Department of General Surgery, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou 310016, China; Co-corresponding author.Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, 100 Blossom St, Cox-734, Boston, MA 02114, USA; Corresponding author.http://www.sciencedirect.com/science/article/pii/S2352396420300190
collection DOAJ
language English
format Article
sources DOAJ
author Jiang Chen
Dan G. Duda
spellingShingle Jiang Chen
Dan G. Duda
Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigms
EBioMedicine
author_facet Jiang Chen
Dan G. Duda
author_sort Jiang Chen
title Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigms
title_short Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigms
title_full Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigms
title_fullStr Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigms
title_full_unstemmed Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigms
title_sort overcoming sorafenib treatment-resistance in hepatocellular carcinoma: a future perspective at a time of rapidly changing treatment paradigms
publisher Elsevier
series EBioMedicine
issn 2352-3964
publishDate 2020-02-01
url http://www.sciencedirect.com/science/article/pii/S2352396420300190
work_keys_str_mv AT jiangchen overcomingsorafenibtreatmentresistanceinhepatocellularcarcinomaafutureperspectiveatatimeofrapidlychangingtreatmentparadigms
AT dangduda overcomingsorafenibtreatmentresistanceinhepatocellularcarcinomaafutureperspectiveatatimeofrapidlychangingtreatmentparadigms
_version_ 1725844716267765760

Similar Items